- Magda Wierzycka is in talks with the Serum Institute of India about developing a vaccine for South Africa
- She is also negotiating on procuring 10 million doses of the vaccine for South Africa
- The EFF is furious that Wierzycka, a C17 campaign donor, is involved with the procurement and has accused President Cyril Ramaphosa of rewarding his backers
Magda Wierzycka is one of the richest people in South Africa and she wants to get involved with procuring Covid-19 vaccines for South Africa.
The EFF are furious, they believe that a rich white woman is involved in the vaccine procurement programme.
The political party released a statement on Twitter in which they accuse President Cyril Ramaphosa of rewarding his campaign donors with lucrative deals.
According to News24 Wierzycka's company Sygnia is in talks with the Serum Institute of India about developing a new vaccine and to secure 10 million doses for South Africa.
The Twitter post also states that the vaccine has already proved to be useless and will not stop Covid-19 from spreading. The EFF even label Wierzycka as a pre-paid puppet of Ramaphosa.
Wierzycka backed Ramaphosa in his C17 campaign and the EFF have demanded that Ramaphosa release the details of Wierzycka and her company Sygnia in the vaccine procurement.
In a Twitter post, Wierzycka revealed that many of the investors in her company have shares in the company which owns the IP for the AstraZeneca Oxford Covid-19 vaccine.
"Incredible news on Oxford vaccine project. Many Sygnia investors have a small stake in the company which owns the IP. The benefits of offshore diversification."
Wierzycka was born in Poland and moved to South Africa when she was just 13 and has risen through the ranks and become a powerful businesswoman.
Julius Malema has been very critical of millionaires enriching themselves during the pandemic according to The South African.
Earlier, Briefly.co.za reported that Health Minister Dr Zweli Mkhize says that the deal to purchase the AstraZeneca vaccine from the Serum Institute in India was struck before the new Covid-19 variant was discovered in South Africa.
This comes shortly after Mkhize announced that the rollout of the vaccine would be halted, a disappointing announcement to the 1.2 million healthcare workers waiting to receive protection from the virus.
The decision came hot on the heels of a clinical trial that showed doses were ineffective in around 2 000 patients infected with the new strain of the coronavirus.
In other news, the World Health Organization has issued a warning that nations shouldn't be in a hurry to dismiss the AstraZeneca Covid-19 vaccine.
This comes after research showed the vaccine is less effective against the variant discovered locally.
The organisation insisted that AstraZeneca remains a crucial, life-saving tool against the pandemic.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!